Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „baseline“
Suchtreffer
Begriffe & Kennungen
Lynparza · 4.8 · Baseline testing, followed by monthly monitoring of complete blood counts is recommended for the first 12 mont
Eintrag öffnenLynparza · 4.8 · The incidence of elevations in mean corpuscular volume from low or normal at baseline to above the ULN was app
Eintrag öffnenMaviret · 4.8 · 12 discontinuation. All subjects with baseline ALT greater than 3x ULN improved from baseline by the final tre
Eintrag öffnenMounjaro · 4.8 · In SURPASS-CVOT, at month 36, treatment with tirzepatide resulted in mean increases from baseline in pancreati
Eintrag öffnenMounjaro · 4.8 · The percentage of patients who had a change of baseline heart rate of > 20 bpm for 2 or more consecutive visit
Eintrag öffnenMvasi · 4.8 · The risk of bevacizumab-associated hypertension did not correlate with the patients’ baseline characteristics,
Eintrag öffnenOdefsey · 4.8 · 18 lipoprotein (HDL)-cholesterol, and triglycerides at Week 144. The median increase from baseline for these p
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · 11 15 Changes in total fasting cholesterol levels from normal at baseline (< 4.39 mmol/l) to high (≥ 5.17 mmol
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) wa
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) wa
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) wa
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) wa
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · 24 1 Clinically significant weight gain was observed across all baseline Body Mass Index (BMI) categories. Fol
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · 54 1 Clinically significant weight gain was observed across all baseline Body Mass Index (BMI) categories. Fol
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · High uric acid 10 1 Clinically significant weight gain was observed across all baseline Body Mass Index (BMI)
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · High uric acid 10 1 Clinically significant weight gain was observed across all baseline Body Mass Index (BMI)
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high (≥ 1.467 14
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · mmol/l) and changes in fasting triglycerides from borderline at baseline (≥ 1.016 mmol/l - < 1.467 mmol/l) to
Eintrag öffnenOlanzapine Glenmark · 4.8 · 1 Clinically significant weight gain was observed across all baseline Body Mass Index (BMI) categories. Follow
Eintrag öffnenOlanzapine Glenmark · 4.8 · 1 Clinically significant weight gain was observed across all baseline Body Mass Index (BMI) categories. Follow
Eintrag öffnen